Antitubercular agent 34 (compound 42g) effectively inhibits Mtb H37Rv growth, exhibiting a MIC 90 value of 1.25 µg/mL and demonstrates resistance to metabolic degradation by human liver microsomes, proving its potential for tuberculosis research [1].

抗结核药物34（0-20 μg/mL；3-4 d）对Mtb H37Rv显示抑制作用，MIC 90值为1.25 μg/mL [1]。抗结核药物34（0-100 μM；3 d）对人类单核细胞THP-I细胞系也展现抑制效果 [1]。